drugset
drugset / Trial / NCT01281462

Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections

NCT01281462 ↗

Phase 2 Completed 217 enrolled Forest Laboratories
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study in adult subjects with complicated urinary tract infection (cUTI) comparing treatment with intravenous (IV) coadministered ceftaroline fosamil and NXL104 versus treatment with IV doripenem.

Timeline

Start
2010-12
Primary completion
2012-03
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftaroline fosamil Other / unclassified 600 mg Intravenous
Comparator Doripenem Small molecule 500 mg Intravenous
Subject avibactam Small molecule 600 mg Intravenous

Indications

urinary tract infection